O'Shaughnessy Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $1,754 - $2,928	-106 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $2,884 - $4,346	106 New	106 $3,000
Q1 2020 May 13, 2020	SELL	$19.54 - $38.85 $2,071 - $4,118	-106 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$17.95 - $29.41 $1,902 - $3,117	106 New	106 $3,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.46B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.